joimax<sup>®</sup> announces 510(k) clearance for its Endovapor<sup>®</sup> 2 Multi Radio Frequency System with its first presentation at the Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) 2017, in Los Angeles

joimax® announces 510(k) clearance for its Endovapor® 2 Multi Radio Frequency System with its first presentation at the Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) 2017, in Los Angeles

Irvine, CA – April 26, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor® 2 Multi Radio Frequency System. The patented device generates electrical power for monopolar and bipolar cutting and coagulation of tissue structures in surgical operations. The joimax® Endovapor® 2 is an all-in-one generator with specially integrated progra...
joimax<sup>®</sup>celebrates its 10<sup>th</sup> anniversary presence with 900 users in China and reports a jump in Q1-2017 sales

joimax®celebrates its 10th anniversary presence with 900 users in China and reports a jump in Q1-2017 sales

Karlsruhe, Germany – April 11th, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, just celebrated its 10 years’ birthday in China with an outstanding 3 days event in Chongqing. More than 900 surgeons out of 2,000 users in China only took part in live surgeries, workshops and a scientific program on endoscopic spinal technologies including MISS fusion techniques. Besides, joimax® organized the presentation of its latest systems like the TESSYS® ISeeU and i...
joimax<sup>®</sup> obtains full product registration in Thailand, and is now active in 10 Asian countries

joimax® obtains full product registration in Thailand, and is now active in 10 Asian countries

Karlsruhe, Germany – February 27th, 2017 – joimax® further ensures its market access in Asia. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding its presence and recently has obtained full product registration from the Thai Food & Drug Administration (FDA). joimax® also has approvals in South Korea, China, Singapore, Indonesia, Hong Kong and Vietnam. For Malaysia, Taiwan and Japan, the certification...
joimax<sup>®</sup> shows again strong growth trend in 2016 and gets issued next new patents holding now more than 150 patents and trademarks worldwide

joimax® shows again strong growth trend in 2016 and gets issued next new patents holding now more than 150 patents and trademarks worldwide

Karlsruhe, Germany – January 17th, 2017 – the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery joimax® announces again very satisfying growing sales figures. Record sales in 2016 are representing another 31% growth vs. 2015. This is in line with a Compound Annual Growth Rate (CAGR) from 2007 – 2016 of around 32%. Projections into 2017 show even accelerated growth due to the worldwide increasing adoption rate of the joimax® procedures. joimax® is active...